Roth Capital Reiterates Buy on SkinHealth Systems, Lowers Price Target to $2

SkinHealth

SkinHealth

SKIN

0.00

Roth Capital analyst George Kelly reiterates SkinHealth Systems (NASDAQ: SKIN) with a Buy and lowers the price target from $2.5 to $2.